• ARCpoint appointed Peter Kendall as interim CEO effective June 9, 2026; appointment follows John Constantine stepping down as president and CEO.
• Kendall previously served as president and chief commercialization officer of AI/ML Innovations, CEO of Yurek Pharmacy Group, national director at Medisys Health Group.
• Kendall’s initial term is 90 days; he will review the business model, the MAPL platform, assets, partnerships, strategic direction.
• Constantine shifts to a sales, marketing, commercial development role focused on the MyARCpointLabs platform; he remains a director.
• Board members are Zelong “Roger” He, David Keys, John Constantine, Adam Ho.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARCpoint Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606091900PRIMZONEFULLFEED9734515) on June 09, 2026, and is solely responsible for the information contained therein.